TY - JOUR
T1 - Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks γ-aminobutyric acid-modulatory activity
AU - Todorovic, Slobodan M.
AU - Prakriya, Murali
AU - Nakashima, Yasunori M.
AU - Nilsson, Kent R.
AU - Han, Mingchen
AU - Zorumski, Charles F.
AU - Covery, Douglas F.
AU - Lingle, Christopher J.
PY - 1998/11
Y1 - 1998/11
N2 - A number of steroids seem to have anesthetic effects resulting primarily from their ability to potentiate currents gated by γ-aminobutyric acid(A) (GABA(A)) receptor activation. One such compound is (3α,5α,17β)-3- hydroxyandrostane-17-carbonitrile [(+)-ACN]. We were interested in whether carbonitrile substitution at other ring positions might result in other pharmacological consequences. Here we examine effects of (3β,5α,17β)-17- hydroxyestrane-3-carbonitrile [(+)-ECN] on GABA(A) receptors and Ca2+ channels. In contrast to (+)-ACN, (+)-ECN does not potentiate GABA(A)- receptor activated currents, nor does it directly gate GABA(A)-receptor mediated currents. However, both steroids produce an enantioselective reduction of T-type current. (+)-ECN blocked T current with an IC50 value of 0.3 μU with a maximal block of 41%. (+)-ACN produced a partial block of T current (44% maximal block) with an IC50 value of 0.4 μM. Block of T current showed mild use- and voltage-dependence. The (-)-ECN enantiomer was about 33 times less potent than (+)-ECN, with an IC50 value of 10 μU and an amount of maximal block comparable to (+)-ECN. (+)-ECN was less effective at blocking high-voltage-activated Ca2+ current in DRG neurons (IC50 value of 9.3 μU with maximal block of about 27%) and hippocampal neurons. (+)-ECN (10 μM) had minimal effects on voltage-gated sodium and potassium currents in rat chromaffin cells. The results identify asteroid with no effects on GABA(A) receptors that produces a partial inhibition of T-type Ca2+ current with reasonably high affinity and selectivity. Further study of steroid actions on T currents may lead to even more selective and potent agents.
AB - A number of steroids seem to have anesthetic effects resulting primarily from their ability to potentiate currents gated by γ-aminobutyric acid(A) (GABA(A)) receptor activation. One such compound is (3α,5α,17β)-3- hydroxyandrostane-17-carbonitrile [(+)-ACN]. We were interested in whether carbonitrile substitution at other ring positions might result in other pharmacological consequences. Here we examine effects of (3β,5α,17β)-17- hydroxyestrane-3-carbonitrile [(+)-ECN] on GABA(A) receptors and Ca2+ channels. In contrast to (+)-ACN, (+)-ECN does not potentiate GABA(A)- receptor activated currents, nor does it directly gate GABA(A)-receptor mediated currents. However, both steroids produce an enantioselective reduction of T-type current. (+)-ECN blocked T current with an IC50 value of 0.3 μU with a maximal block of 41%. (+)-ACN produced a partial block of T current (44% maximal block) with an IC50 value of 0.4 μM. Block of T current showed mild use- and voltage-dependence. The (-)-ECN enantiomer was about 33 times less potent than (+)-ECN, with an IC50 value of 10 μU and an amount of maximal block comparable to (+)-ECN. (+)-ECN was less effective at blocking high-voltage-activated Ca2+ current in DRG neurons (IC50 value of 9.3 μU with maximal block of about 27%) and hippocampal neurons. (+)-ECN (10 μM) had minimal effects on voltage-gated sodium and potassium currents in rat chromaffin cells. The results identify asteroid with no effects on GABA(A) receptors that produces a partial inhibition of T-type Ca2+ current with reasonably high affinity and selectivity. Further study of steroid actions on T currents may lead to even more selective and potent agents.
UR - http://www.scopus.com/inward/record.url?scp=0031724394&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031724394&partnerID=8YFLogxK
U2 - 10.1124/mol.54.5.918
DO - 10.1124/mol.54.5.918
M3 - Article
C2 - 9804627
AN - SCOPUS:0031724394
SN - 0026-895X
VL - 54
SP - 918
EP - 927
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 5
ER -